Influenza

Nov 18, 2025

FDA Approves Major Safety and Indication Updates for Sarepta's ELEVIDYS Gene Therapy Sarepta Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved significant updates to the prescribing information for its Duchenne muscular dystrophy (DMD) gene therapy, ELEVIDYS (delandistrogene mo...

May 14, 2025

The pharmaceutical industry stands at a crossroads, where innovation is no longer a luxury but a necessity. The AI in the drug discovery market is at the forefront of this transformation, driven by the remarkable capabilities of generative AI. This technology, which creates novel solutions by learning from vast dat...

Mar 30, 2020

COVID-19, a novel coronavirus after toppling down China, has managed to create havoc in the entire world, with people fearing the impending doom.  This is no news that novel coronavirus – SARS CoV-2 – was first originated in Wuhan and now has clawed the whole world. The spread has become unstoppable, with o...

Dec 02, 2019

Influenza, we are ready to fight. This year, the National Influenza Vaccination Week, observed in the first week of December month, i.e. December 1-7, 2019. The aim is to create awareness about different infections and their treatments across the world. Influenza is an infectious disease caused by the influenza...

Jul 11, 2019

Osivax raises USD 9 M to boost its universal flu vaccine approach France based biotech startup company Osivax, has secured USD 9 million in Series A financing. A Belgian-based firm Noshaq along with Anaxago, an innovative investment platform led the financing. The proceeds will be used to further advance the cl...